68Ga-DOTA-IBA PET/CT and 18F-FDG PET/CT in Ewing Sarcoma
A 29-year-old man with Ewing sarcoma in the right ankle underwent 68 Ga-DOTA-IBA PET/CT and 18 F-FDG PET/CT, both of which showed high radiotracer activity for the primary tumor. Interestingly, bone metastases were detected early using 68 Ga-DOTA-IBA PET/CT for the sixth thoracic vertebrae and with 18 F-FDG PET/CT for the bilateral humerus. Higher uptake of 68 Ga-DOTA-IBA was found in both primary and metastatic sites of Ewing sarcoma. 177 Lu-DOTA-IBA may be one of the possible therapies for metastatic or recurrent Ewing sarcoma.
Authors
- Wenzhe Ma (ORCID: https://orcid.org/0000-0001-9475-6981)
- Feifan Xiang (ORCID: https://orcid.org/0000-0001-9019-5515)
- Xiaoqi Tan (ORCID: https://orcid.org/0000-0003-1765-3078)
- Huipan Liu (ORCID: https://orcid.org/0000-0001-7328-4241)
- Yue Chen (ORCID: https://orcid.org/0000-0002-1011-2781)
Institutions
- Macau University of Science and Technology (MO)
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- First Affiliated Hospital of Sichuan Medical University (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1097/rlu.0000000000005402
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00